Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug,...

Researchers say pemetrexed (Alimta), the top chemotherapy drug for mesothelioma, may carry a risk of acute kidney injury, even in patients whose baseline kidney function falls within recommended...(PRWeb July 16, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12014002.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news